Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma
SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma
Long-Term Remissions Shown With Chemo Plus Radiation
Raloxifene Protects Women At High or Low Risk of Disease
Study Needs 23,000 Women Whose Sisters Have Cancer
Tamoxifen: No Mortality Benefit For Most “High Risk” Women
Breast Density As Important As Age In Determining Risk
Ovariectomy Without HRT Increases Death Rate
NCI-Approved Clinical Trials
Trending Stories
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed
- NCI releases names of members of ad hoc working group—filling the void left by BSA
- The Directors: Ben Ho Park and Suresh Ramalingam discuss tough times, uncertainty, and resilience
“If you’re going to be an oncologist, we look at the glass 5% full, not 95% empty.” - Reflections of a cancer scientist
Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - Nobel laureate David Baltimore dies at 87
Baltimore discovered that genetic material of tumor viruses could make DNA from their RNA genome